The State of Infectious Diseases Clinical Trials: A Systematic Review of ClinicalTrials.gov

Background There is a paucity of clinical trials informing specific questions faced by infectious diseases (ID) specialists. The ClinicalTrials.gov registry offers an opportunity to evaluate the ID clinical trials portfolio. Methods We examined 40,970 interventional trials registered with ClinicalTrials.gov from 2007–2010, focusing on study conditions and interventions to identify ID-related trials. Relevance to ID was manually confirmed for each programmatically identified trial, yielding 3570 ID trials and 37,400 non-ID trials for analysis. Results The number of ID trials was similar to the number of trials identified as belonging to cardiovascular medicine (n = 3437) or mental health (n = 3695) specialties. Slightly over half of ID trials were treatment-oriented trials (53%, vs. 77% for non-ID trials) followed by prevention (38%, vs. 8% in non-ID trials). ID trials tended to be larger than those of other specialties, with a median enrollment of 125 subjects (interquartile range [IQR], 45–400) vs. 60 (IQR, 30–160) for non-ID trials. Most ID studies are randomized (73%) but nonblinded (56%). Industry was the funding source in 51% of ID trials vs. 10% that were primarily NIH-funded. HIV-AIDS trials constitute the largest subset of ID trials (n = 815 [23%]), followed by influenza vaccine (n = 375 [11%]), and hepatitis C (n = 339 [9%]) trials. Relative to U.S. and global mortality rates, HIV-AIDS and hepatitis C virus trials are over-represented, whereas lower respiratory tract infection trials are under-represented in this large sample of ID clinical trials. Conclusions This work is the first to characterize ID clinical trials registered in ClinicalTrials.gov, providing a framework to discuss prioritization, methodology, and policy.

[1]  Nicholas C. Ide,et al.  Issues in the registration of clinical trials. , 2007, JAMA.

[2]  Roundtable on Value.  Forum on Drug Discovery, Development, and Translation , 2013 .

[3]  A. Widmer.  New developments in diagnosis and treatment of infection in orthopedic implants. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[4]  Alexa T. McCray,et al.  Design, Implementation and Management of a Web-Based Data Entry System for ClinicalTrials.gov , 2004, MedInfo.

[5]  C. Mathers.  Global Burden of Disease , 2008 .

[6]  S. Kurtz,et al.  Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030. , 2007, The Journal of bone and joint surgery. American volume.

[7]  C. Gill.  How often do US-based human subjects research studies register on time, and how often do they post their results? A statistical analysis of the Clinicaltrials.gov database , 2012, BMJ Open.

[8]  R. Darouiche,et al.  Treatment of infections associated with surgical implants. , 2004, The New England journal of medicine.

[9]  L. Johnson,et al.  The Infectious Diseases Society of America Lyme guidelines: a cautionary tale about the development of clinical practice guidelines , 2010, Philosophy, ethics, and humanities in medicine : PEHM.

[10]  M. Weyden.  The International Committee of Medical Journal Editors , 2006 .

[11]  L. Baddour,et al.  Quality and strength of evidence of the Infectious Diseases Society of America clinical practice guidelines. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[12]  A. Tsien,et al.  Food and Drug Administration Modernization Act , 2004 .

[13]  W. Eyler.  Uniform requirements for manuscripts submitted to biomedical journals. , 1980, Canadian Medical Association journal.

[14]  Ricardo Pietrobon,et al.  The Database for Aggregate Analysis of ClinicalTrials.gov (AACT) and Subsequent Regrouping by Clinical Specialty , 2012, PloS one.

[15]  Nicholas C. Ide,et al.  The ClinicalTrials.gov results database--update and key issues. , 2011, The New England journal of medicine.

[16]  Robert M Califf,et al.  Characteristics of clinical trials registered in ClinicalTrials.gov, 2007-2010. , 2012, JAMA.

[17]  Nicholas C. Ide,et al.  Trial Registration at ClinicalTrials.gov between May and October 2005. , 2005, The New England journal of medicine.

[18]  D. Lee,et al.  Analysis of overall level of evidence behind Infectious Diseases Society of America practice guidelines. , 2011, Archives of internal medicine.

[19]  黄亚明（整理）,et al.  ICMJE , 2012 .

[20]  W. Petri,et al.  Setting Research Priorities to Reduce Mortality and Morbidity of Childhood Diarrhoeal Disease in the Next 15 Years , 2013, PLoS medicine.